Coherus Biosciences(CHRS)
$0.37-0.02 (-4.65%)
CHRS
Coherus Biosciences earnings date
$0.37
At close:-0.02 (-4.65%)
Want to see CHRS full AI Analyst Report?
Coherus Biosciences (CHRS) Q2 2026 Earnings Report
1,706 Followers
CHRS Q2 2026 EPS Results
- Actual EPS
- -$0.22
- Consensus EPS
- -$0.25
- Beat/Miss
- Beat by +$0.03
- One Year Ago EPS
- -$0.39
CHRS Q2 2026 Revenue Results
- Actual Revenue
- $14.31M
- Expected Revenue
- $14.41M
- Beat/Miss
- Missed by -$99.00K
- YoY Revenue Growth
- +39.53%
Earnings Announcement Details
- Quarter
- Q2 2026
- Date
- 08/05/2026
- Time
- During Market Hours
- Conference Call
- Wednesday, August 5, 2026
CHRS Upcoming Earnings
Coherus Biosciences's next earnings date is estimated for March 15, 2027, based on past reporting schedules.
Q2 2026 Earnings Call Audio
CHRS Q2 2026 Earnings Call
0:00 / 0:00
Q2 2026 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2026 Earnings Call Summary
No earnings call summary is available for this earnings event.
CHRS Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 15, 2027 | 2026 (Q4) | -0.20- | -0.39 | ― | ― |
| Nov 09, 2026 | 2026 (Q3) | -0.22-0.25 | -0.31 | 19.35% (+0.06) | |
| Aug 05, 2026 | 2026 (Q2) | -0.25-0.22 | -0.39 | 43.59% (+0.17) | |
| May 11, 2026 | 2026 (Q1) | -0.22-0.27 | -0.41 | 34.15% (+0.14) | |
| Mar 09, 2026 | 2025 (Q4) | -0.35-0.39 | -0.44 | 11.36% (+0.05) | |
| Nov 06, 2025 | 2025 (Q3) | -0.35-0.31 | -0.09 | -244.44% (-0.22) | |
| Aug 07, 2025 | 2025 (Q2) | -0.22-0.39 | -0.11 | -254.55% (-0.28) | |
| May 12, 2025 | 2025 (Q1) | -0.30-0.41 | 0.83 | -149.40% (-1.24) | |
| Mar 10, 2025 | 2024 (Q4) | -0.31-0.44 | -0.71 | 38.03% (+0.27) | |
| Nov 06, 2024 | 2024 (Q3) | -0.16-0.09 | -0.41 | 78.05% (+0.32) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
